|
Quality Assurance |
|
 |
Albert
David Limited (ADL), a prominent drug house,
distinguished in the field of manufacturing
Pharmaceutical Formulations, Infusion Solutions,
Herbal Dosage Forms, Bulk Drugs and Disposable
Syringes & Needles has its base in Kolkata, India.
The company belongs to a renowned industrial house
of Kolkata, the "Kothari Group, India". Equipped
with cutting edge research and development standard
and scientific skill, the best brains work here to
develop new products for the demanding marketplace
worldwide.
Albert David has pioneered the practices of so many
modern techniques in many of its research work and
implemented innovative ideas. Innovation is a
culture here and governs every strategies of the
company. We have our state-of-the-art manufacturing
facilities in three different parts of the country.
The Kolkata manufacturing units is a WHO GMP
approved unit and Small Volume Parental suite
compliant to USFDA cGMP requirements. Another unit
is located at Gaziabad, New Delhi. This unit is ISO
9001:2008 certified plant. The third unit is located
at Mandideep, near Bhopal.
|
|
This unit
has the Certificate of Pharmaceutical Products under
WHO - GMP Certification Scheme with unique
distinction of achieving and acquiring quality
accreditation of ISO 9001:2008, ISO 13485:2003 and
CE Certification through DNV NORWAY.
Albert
David's core strength lies in its vibrant team of
1500 plus employees and its continuous effort to
bring out the best and become the best. The Sales
turnover was close to Rs. 320 Crores (Approximately USD 48 Million) in the year ended 31st March 2015.
With an extensive network of 1600 plus Stockists in
various parts of the country, we are able to make
our products available in each and every corner of
the country. ADL also has significant presence in
South East Asia, Africa, countries of Middle - East,
Europe, USA and Latin America, covering almost 35
countries.
A pioneer product Sodium stibogluconate which is
used to treat leishmaniasis has been manufactured by
Albert David Ltd, Calcutta, and is sold under the
name Sodium Antimony Gluconate and distributed
worldwide through IDA Amesterdam.
Another breakthrough product is 'Placentrex' derived
from the extract of fresh term healthy human
placenta. The Company has come a long way and
identified the nucleotides and peptides responsible
for anti-inflammatory, wound healing and tissue
regenerative property.
The Company is in strategic liaison with academic
institutes like Indian Institute of Chemical Biology
(CSIR) & Department of Biotechnology, Calcutta
University for outsourcing of research. |
| |
|
R&D
activities & Achievements - Albert David Limited (ADL),
a prominent drug house, distinguished in the field
of manufacturing Pharmaceutical Formulations,
Infusion Solutions, Herbal Dosage Forms, Bulk Drugs
and Disposable Syringes & Needles has its base in
Kolkata, India. The company belongs to a renowned
industrial house of Kolkata, the "Kothari Group,
India". Equipped with cutting edge research and
development standard and scientific skill, the best
brains work here to develop new products for the
demanding marketplace worldwide.
Albert David has pioneered the practices of so many
modern techniques in many of its research work and
implemented innovative ideas. Innovation is a
culture here and governs every strategies of the
company. We have our state-of-the-art manufacturing
facilities in three different parts of the country.
The Kolkata manufacturing units is a WHO GMP
approved unit and Small Volume Parental suite
compliant to USFDA cGMP requirements. Another unit
is located at Ghaziabad, New Delhi. This unit is ISO
9001:2008 certified plant. The third unit is located
at Mandideep, near Bhopal. This unit has the
Certificate of Pharmaceutical Products under WHO - GMP Certification Scheme with unique distinction of
achieving and acquiring quality accreditation of ISO
9001:2008, ISO 13485:2003 and CE Certification
through DNV NORWAY.
Albert David's core strength lies in its vibrant
team of 1500 plus employees and its continuous
effort to bring out the best and become the best.
The Sales turnover was close to Rs. 320 Crores (
Approximately USD 48 Million ) in the year ended
31st March 2015. With an extensive network of 1600
plus Stockists in various parts of the country, we
are able to make our products available in each and
every corner of the country. ADL also has
significant presence in South East Asia, Africa,
countries of Middle - East, Europe, USA and Latin
America, covering almost 35 countries.
A pioneer product Sodium stibogluconate which is
used to treat leishmaniasis has been manufactured by
Albert David Ltd, Calcutta, and is sold under the
name Sodium Antimony Gluconate and distributed
worldwide through IDA Amesterdam.
Another breakthrough product is 'Placentrex' derived
from the extract of fresh term healthy human
placenta. The Company has come a long way and
identified the nucleotides and peptides responsible
for anti-inflammatory, wound healing and tissue
regenerative property.
The Company is in strategic liaison with academic
institutes like Indian Institute of Chemical Biology
(CSIR) & Department of Biotechnology, Calcutta
University for outsourcing of research. |
| |
|
Most of
the findings have been published in journals of
national and international repute.
Ongoing Projects of R&D -
 |
Development of Solid Oral Dosage forms of anti
- Leishmaniasis
drug Miltefosine to introduce latest line of
treatment of Leishmaniasis. |
|
|
Biochemical characterization of the drug Placentrex and identifying it's active components
and their mode of action. Further for label claim of
the active components of "Placentrex". |
|
|
Characterization of therapeutic principles of Placentrex to identify the active components and
their mechanism of action. |
|
|
Development of Solid Oral Dosage form of amino
acids and hydroxy - analogue & Keto - analogues of amino
acids for treatment of Uremia. |
|
|
Development of intravenous injection and solid
oral dosage forms of Methylcobalamine. |
|
|
For the development of intravenous injection,
solid oral dosage form and sustained release solid
oral dosage forms of Isoxsuprine. |
|
|
Development of Nano particles of FAT Emulsion for
Infusion - A TPN Product for Infusion. |
|
|
Development of the Product Alamin-RG, an amino
acid supplement with arginine. |
|
|
Formulation Development of Tamsulosin product and
its combination products with dutasteride and
finesteride. |
|
|
Standardization of amino acids in Placentrex Gel :
Development of analytical method for export
registration. |
|
|
Development of indigenous synthetic route for Miltefosin
- an anti - Leishmaniasis Drug, for the
development of indigenous capability from API to
Product and Import Substitution. |
|
|
Development of Sodium Stibo Gluconate in single
dosage form (5 ml ampoule) for product extension for
exports. |
|
|
Various Process and product improvement project
plans of existing products for the process and
product quality improvements. |
The direct interaction and such collaboration
between Business conglomerates and academics
certainly helps to discover new molecules & products
for the benefits of the masses, such strong bondages
will be definitely mutually beneficial.
Though this is the humble beginning, we are looking
forward to much bigger involvements, both financial
and academic.
Self Inspection & Auditing - Periodically a separate
area is audited by the internal audit team with
persons responsible for that area. The audit covers
the personnel, premises, equipment, procedures and
documentation. The findings of the inspection are
discussed with the concerned person and the report alongwith recommendations is submitted to the
in-charge of the concerned department for necessary
action. The result of the periodic and annual
inspection is maintained by the quality assurance
department. |
| |
|
|
Objectives |
|
|
To provide the
safest formulation in different dosage forms
in the market. |
|
|
To keep the
equipment, the process and the products
updated with technological advance
corresponding to international quality
standards. |
|
|
To satisfy our
customers within India and abroad with
timely delivery and "zero defect" product. |
|
|
To ensure cost
effective systems in our operations and to
achieve quality and productivity. |
|
|
To enhance
productivity through improved working
methods and motivated employees |
|
|
To encourage
employee's involvement at par with the
management and to achieve congenial and
healthy working atmosphere. |
|
|
To provide
efficient service to the customers. |
|
|
Development for
new formulations is carried out by R&D Team. |
|
|
|
Assurance |
|
Monitoring of quality
standard / good manufacturing practices at each and
every stage of manufacturing. We strictly follow the
following factors to achieve quality products :
|
|
Selection and
control of drug component - RM/PM |
|
|
For parenteral
products quality - special processing of
water system is required including dimineralization / multi column distillation
to get high quality WFI. |
|
|
Manufacturing
environment control - giving special
classroom facilities to control air borne
particulate matter and micro-organizms. |
|
|
Proper selection
of filtration system - to control liquid
borne particulate matter Selection & control of sterilization
methods to control viable micro-organisms. |
|
|
Selection of
proper labelling and packaging to meet drug
regulation / market acceptance
|
|
| |
|
